Potential use of glucocorticosteroids in CSF1R mutation carriers - current evidence and future directions.

Dulski, Jaroslaw; Stanley, E Richard; Chitu, Violeta; Wszolek, Zbigniew K

Dulski, Jaroslaw; Stanley, E Richard; Chitu, Violeta; Wszolek, Zbigniew K.

Afiliação

Dulski J; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Stanley ER; Division of Neurological and Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland.
Chitu V; Neurology Department, St Adalbert Hospital, Copernicus PL Ltd., Gdansk, Poland.
Wszolek ZK; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, NY, United States.

Neurol Neurochir Pol ; 57(5): 444-449, 2023.

Article em En | MEDLINE | ID: mdl-37889001

Assuntos

Leucoencefalopatias; Animais; Humanos; Camundongos; Leucoencefalopatias/genética; Mutação

Palavras-chave

glucocorticosteroids; hereditary; leukoencephalopathy; spheroids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucoencefalopatias Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google